News

Stay informed about Enzene Biosciences, keep up with the latest news and stay at the forefront of industry advancements.

Enzene wins CPHI manufacturing excellence award

Enzene wins CPHI manufacturing excellence award

Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO), today welcomed the news that its EnzeneX™ 2.0 platform, featuring fully-connected continuous manufacturing™ (FCCM™) technology, won the 2025 CPHI Pharma Award for Manufacturing Excellence.

Filter by:

Months:

Years:

Enzene wins CPHI manufacturing excellence award

Enzene wins CPHI manufacturing excellence award

Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO), today welcomed the [...]

Enzene and Virtuosi® Partner to Advance Global Standards in Biopharmaceutical Workforce Excellence

Enzene and Virtuosi® Partner to Advance Global Standards in Biopharmaceutical Workforce Excellence

Enzene Biosciences Ltd., a leading Continuously Innovative Development and Manufacturing Organization (CIDMO) in the bio [...]

Enzene Enables Commercial Supply Of Pertuzumab For The Treatment Of Breast Cancer

Enzene Enables Commercial Supply Of Pertuzumab For The Treatment Of Breast Cancer

Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO), today announced the [...]

Governor Murphy Inaugurates New US Continuous Biomanufacturing Facility of India-Based Enzene

Governor Murphy Inaugurates New US Continuous Biomanufacturing Facility of India-Based Enzene

Governor Phil Murphy yesterday officially inaugurated the state-of-the-art biomanufacturing facility of Enzene, a leadin [...]

Ahead of Opening, Enzene Expands Scope for Biomanufacturing at New Jersey Site

Ahead of Opening, Enzene Expands Scope for Biomanufacturing at New Jersey Site

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that ahead of the of [...]

Enzene Receives EU GMP Certification for its Facilities in India

Enzene Receives EU GMP Certification for its Facilities in India

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that its two facilit [...]

Enzene Biosciences launches biosimilar Ranibizumab

Enzene Biosciences launches biosimilar Ranibizumab

Enzene Biosciences has now launched Ranibizumab, a biosimilar to innovator product Lucentis® that is sold under the bran [...]

Enzene Biosciences launches biosimilar Adalimumab

Enzene Biosciences launches biosimilar Adalimumab

Enzene Biosciences Ltd. has announced that it has begun commercial supplies of Adalimumab for treating Ankylosis Spondyl [...]

Enzene Biosciences launches Bevacizumab

Enzene Biosciences launches Bevacizumab

Enzene Biosciences has now announced the India launch of Bevacizumab, a biosimilar of Avastin® that is used for the trea [...]

Enzene Biosciences launches Cetuximab

Enzene Biosciences launches Cetuximab

Enzene Biosciences has launched Cetuximab as the first biosimilar treatment option for a wide range of ailments like can [...]

Enzene Biosciences unveils cutting-edge 75,000 sq. ft R&D facility in Pune

Enzene Biosciences unveils cutting-edge 75,000 sq. ft R&D facility in Pune

Enzene announces inauguration of new state-of-the-art research and development facility in Pune

Enzene launches Discovery Services division at BIO 2024

Enzene launches Discovery Services division at BIO 2024

Enzene Biosciences, a leading global CDMO known for its flagship fully-connected continuous manufacturing platform (Enze [...]

Enzene Biosciences launches its first manufacturing base in the US, at its New Jersey site

Enzene Biosciences launches its first manufacturing base in the US, at its New Jersey site

The 54,000 square feet New Jersey plant can cater to future expansion plans and establishes Enzene Inc. as a premier glo [...]

Enzene Launches EnzeneX™ 2.0

Enzene Launches EnzeneX™ 2.0

Enzene Launches EnzeneX™ 2.0: The Next Generation of its Fully-Connected Continuous Manufacturing™ (FCCM™) Technology fo [...]

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Enzene appoints new site lead for flagship US continuous biomanufacturing facility

Enzene appoints Norm Stoffregen as SVP, site head at Enzene's new $50M manufacturing facility in New Jersey

ADVANZ PHARMA and Enzene enter an exclusive partnership for biosimilar development and commercialisation

ADVANZ PHARMA and Enzene enter an exclusive partnership for biosimilar development and commercialisation

ADVANZ PHARMA Holdco Limited and Enzene Biosciences today announced a strategic partnership for the commercialisation of [...]

Enzene Biosciences launches its first manufacturing base in the US

Enzene Biosciences launches its first manufacturing base in the US

The company has leased 54,000 square feet of space to host multiple manufacturing lines of its continuous manufacturing [...]

Enzene obtains Marketing Authorization for its first Biosimilar molecule in India

Enzene obtains Marketing Authorization for its first Biosimilar molecule in India

Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller Genera [...]

Enzene Opens its First Continuous Biologics Manufacturing Facility

Enzene Opens its First Continuous Biologics Manufacturing Facility

Enzene Biosciences today formally opened its first fully connected continuous Biologics manufacturing facility in Pune, [...]